These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 36601545)
1. Can't keep it SECRET: system evaluation of carbapenem restriction against empirical therapy. Wells DA; Johnson AJ; Lukas JG; Hobbs DA; Cleveland KO; Twilla JD; Hobbs ALV JAC Antimicrob Resist; 2023 Feb; 5(1):dlac137. PubMed ID: 36601545 [TBL] [Abstract][Full Text] [Related]
2. Criteria Restricting Inappropriate Meropenem Empiricism (CRIME): a quasi-experimental carbapenem restriction pilot at a large academic medical centre. Wells DA; Johnson AJ; Lukas JG; Mason D; Cleveland KO; Bissell A; Hobbs ALV Int J Antimicrob Agents; 2022 Oct; 60(4):106661. PubMed ID: 35988667 [TBL] [Abstract][Full Text] [Related]
3. Leveling Up: Evaluation of IV v. PO Linezolid Utilization and Cost after an Antimicrobial Stewardship Program Revision of IV to PO Conversion Criteria within a Healthcare System. Jaggar J; Cleveland KO; Twilla JD; Patterson S; Hobbs ALV Pharmacy (Basel); 2023 Apr; 11(2):. PubMed ID: 37104076 [TBL] [Abstract][Full Text] [Related]
4. Impact of an infectious disease physician-led carbapenem postprescription feedback on prescribing behavior in a Japanese tertiary hospital: A before-after study. Matono T; Umeda Y; Uchida M; Koga H; Kanatani N; Furuno Y; Yamashita T; Nakamura K J Infect Chemother; 2021 Mar; 27(3):439-444. PubMed ID: 33129693 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a carbapenem antimicrobial stewardship program and clinical outcomes in a Japanese hospital. Komatsu T; Inagaki R; Azuma S; Mochida S; Sato Y; Seto Y; Nihonyanagi S; Hoshiyama T; Wada T; Takayama Y; Atsuda K J Infect Chemother; 2022 Jul; 28(7):884-889. PubMed ID: 35331613 [TBL] [Abstract][Full Text] [Related]
6. Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program. Faraone A; Poggi A; Cappugi C; Tofani L; Riccobono E; Giani T; Fortini A Eur J Intern Med; 2020 Aug; 78():50-57. PubMed ID: 32303455 [TBL] [Abstract][Full Text] [Related]
7. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Al-Hasan MN; Acker EC; Kohn JE; Bookstaver PB; Justo JA Pharmacotherapy; 2018 Jan; 38(1):42-50. PubMed ID: 29105102 [TBL] [Abstract][Full Text] [Related]
8. Impact of the antimicrobial stewardship program on hospital-acquired candidemia. Hadano Y; Suyama A; Miura A; Fujii S; Suzuki Y; Tomoda Y; Awaya Y Sci Rep; 2022 Sep; 12(1):15135. PubMed ID: 36071095 [TBL] [Abstract][Full Text] [Related]
9. Impact of an Antimicrobial Stewardship Intervention on the Appropriateness of Carbapenem Use at a Tertiary Hospital in Malaysia. Chang CY; Devi Nath N; Lam K; Zaid M Cureus; 2022 Nov; 14(11):e31660. PubMed ID: 36540495 [TBL] [Abstract][Full Text] [Related]
10. Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship. Yoon YK; Yang KS; Lee SE; Kim HJ; Sohn JW; Kim MJ PLoS One; 2014; 9(6):e99101. PubMed ID: 24911244 [TBL] [Abstract][Full Text] [Related]
11. Handshake stewardship reduces carbapenem prescription in a pediatric critical care setting. Kit-Anan W; Boonsathorn S; Anantasit N; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N Pediatr Int; 2022 Jan; 64(1):e15227. PubMed ID: 35912458 [TBL] [Abstract][Full Text] [Related]
12. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. Horikoshi Y; Suwa J; Higuchi H; Kaneko T; Furuichi M; Aizawa Y; Fukuoka K; Okazaki K; Ito K; Shoji T Int J Infect Dis; 2017 Nov; 64():69-73. PubMed ID: 28941633 [TBL] [Abstract][Full Text] [Related]
13. Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan-The Impact of Postprescription Review and Feedback. Akazawa T; Kusama Y; Fukuda H; Hayakawa K; Kutsuna S; Moriyama Y; Ohashi H; Tamura S; Yamamoto K; Hara R; Shigeno A; Ota M; Ishikane M; Tokita S; Terakado H; Ohmagari N Open Forum Infect Dis; 2019 Oct; 6(10):ofz389. PubMed ID: 31660352 [TBL] [Abstract][Full Text] [Related]
14. Impact of the multidisciplinary antimicrobial stewardship team intervention focusing on carbapenem de-escalation: A single-centre and interrupted time series analysis. Suzuki A; Maeda M; Yokoe T; Hashiguchi M; Togashi M; Ishino K Int J Clin Pract; 2021 Mar; 75(3):e13693. PubMed ID: 32893441 [TBL] [Abstract][Full Text] [Related]
15. Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU. Abdallah M; Badawi M; Amirah MF; Rasheed A; Mady AF; Alodat M; Alharthy A J Antimicrob Chemother; 2017 Nov; 72(11):3187-3190. PubMed ID: 28961733 [TBL] [Abstract][Full Text] [Related]
16. Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan. Horikoshi Y; Higuchi H; Suwa J; Isogai M; Shoji T; Ito K J Infect Chemother; 2016 Aug; 22(8):532-5. PubMed ID: 27263807 [TBL] [Abstract][Full Text] [Related]
17. Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitals in Jordan. Yusef D; Hayajneh WA; Bani Issa A; Haddad R; Al-Azzam S; Lattyak EA; Lattyak WJ; Gould I; Conway BR; Bond S; Conlon-Bingham G; Aldeyab MA J Antimicrob Chemother; 2021 Jan; 76(2):516-523. PubMed ID: 33219679 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study. El Masri M; Haddad N; Saad T; Rizk NA; Zakhour R; Kanj SS; Zeenny RM Front Cell Infect Microbiol; 2022; 12():729491. PubMed ID: 35402313 [TBL] [Abstract][Full Text] [Related]
19. Selective antibiotic susceptibility reporting and broad-spectrum intravenous antibiotic use: A multicentre ecological study. Smoke S; Raja K; Narayanan N; Brunetti L Int J Antimicrob Agents; 2019 Sep; 54(3):367-370. PubMed ID: 31202924 [TBL] [Abstract][Full Text] [Related]